Targeting high-precision floating-point arithmetic operations in engineering modeling software, Fast16 may now be the ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has cleared ...